Our products are designed to personalize the treatment of infectious diseases, and improve the lives of patients !
Our Mission
At ID Genomics, Inc., our mission is to guide antibiotic or other treatment correctly the first time by matching the infecting bug with the correct drug. We combine rapid molecular diagnostics with epidemiological surveillance and big-data tools to guide antibiotic choices.
Breakthrough
Our diagnostic assay, CLoNeT™, assigns proprietary barcodes to infecting bacteria by identifying a few fingerprint regions of bacterial DNA. Our lead product is being developed for urinary tract infection (UTI), a common infection that is at the forefront of the antibiotic resistance crisis. CLoNeT™ 1.0 has shown unprecedented safety profiles in preclinical studies, reducing antibiotic prescription errors for UTIs from 25% to less than 3%.
Using Latest Tech
Big-data approaches remove the guesswork in prescribing antibiotics. BactNet™ is a reference metadata repository that links bacterial samples, IDG’s proprietary barcodes, and clinical information with responses to commonly prescribed antibiotics. BactNet™ is expected to be a constantly growing database that matches the evolution and spread of drug-resistant bugs. Combined with our barcodes, this big-data platform holds the potential to improve clinical outcomes for multiple infectious diseases.
Our Services
Microbial Identification, Typing and Genomic Analysis Services
16S rRNA Metagenomics Analysis
a culture-free method that enables genetic analysis of an entire microbial communities’ genomes in a complex sample
MLST sequence typing
provides fine resolution identification to assist with tracking, trending and analyzing your isolates.
S. aureus SPA typing
Inexpensive single-locus typing technique which offers a subtyping resolution comparable to MLST and PFGE.
Antibiotic susceptibility testing
SARS-COV-2
ID Genomics, SPC, is offering rapid sequencing of key genomic regions of SARS-CoV-2 able to distinguish thousands of currently circulating variants, with potential detection of novel variants. Our goal is to empower real-time epidemiological monitoring, outbreak detection and containment, clinical research, and other surveillance tasks requiring rapid response.